Tempol Protects Cardiomyocytes from Nucleoside Reverse Transcriptase Inhibitor-Induced Mitochondrial Toxicity

Documenti analoghi

• Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors
  di: Pao, D, et al.
  Pubblicazione: (2001)
• Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
  di: Marfatia, Yogesh S., et al.
  Pubblicazione: (2014)
• Progressive Mitochondrial Compromise in Brains and Livers of Primates Exposed In Utero to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  di: Divi, Rao L., et al.
  Pubblicazione: (2010)
• Abstracts from the current global literature: Mitochondrial toxicities due to nucleoside reverse transcriptase inhibitors
  di: Jain, Sonia, et al.
  Pubblicazione: (2012)
• Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors
  di: Birkus, Gabriel, et al.
  Pubblicazione: (2002)